Follow The Filings

XERS Xeris Biopharma

Xeris Biopharma earnings company data as of 4:47 AM ET 10/24

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.02 — —
Rev — — —

Insider trades

Open-market buys and sales by XERS's executives, directors and 10% owners in the last 12 months, from their Form 4s

All XERS insider trades
  • None no insider bought on the open market
  • $977K sold by 1 insider outside a trading plan
  • $4.4M sold by 9 insiders under 10b5-1 plans
  1. Steven Pieper See Remarks
    Planned sale
    $47K 5,000 shares at $9.41 0.4% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  2. Kevin McCulloch See Remarks
    Planned sale
    $141K 15,000 shares at $9.41 0.9% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  3. Beth Hecht See Remarks
    Planned sale
    $157K 16,666 shares at $9.41 1.5% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  4. Kevin McCulloch See Remarks
    Planned sale
    $250K 25,000 shares at $10.00 1.5% of stake
    Traded Sep 28 Filed Sep 29
    ↗
  5. Kevin McCulloch See Remarks
    Planned sale
    $127K 15,000 shares at $8.49 0.9% of stake
    Traded Sep 1 Filed Sep 1
    ↗
  6. Steven Pieper See Remarks
    Planned sale
    $43K 5,000 shares at $8.50 0.4% of stake
    Traded Sep 1 Filed Sep 1
    ↗
  7. Beth Hecht See Remarks
    Planned sale
    $141K 16,666 shares at $8.49 1.5% of stake
    Traded Sep 1 Filed Sep 1
    ↗
  8. Steven Pieper See Remarks
    Planned sale
    $43K 5,000 shares at $8.50 0.4% of stake
    Traded Aug 12 Filed Aug 12
    ↗
  9. Kevin McCulloch See Remarks
    Planned sale
    $120K 15,000 shares at $8.02 0.9% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  10. Beth Hecht See Remarks
    Planned sale
    $134K 16,666 shares at $8.01 1.4% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  11. Steven Pieper See Remarks
    Planned sale
    $383K 45,000 shares at $8.52 3.2% of stake
    Traded Jul 6–7 Filed Jul 7
    ↗
  12. Kevin McCulloch See Remarks
    Planned sale
    $723K 90,000 shares at $8.03 5.1% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  13. Beth Hecht See Remarks
    Planned sale
    $134K 16,666 shares at $8.03 1.4% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  14. Marla Persky Director
    Planned sale
    $91K 15,500 shares at $5.90 11% of stake
    Traded Jun 3 Filed Jun 5
    ↗
  15. Dawn Halkuff Director
    Planned sale
    $122K 20,000 shares at $6.09 17% of stake
    Traded Jun 4 Filed Jun 5
    ↗

Also filed in the last 12 months, not counted as buying or selling: 15 share withholdings for taxes, 12 stock grants, and 9 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 3.02,8.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 3.02,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.